News & Articles mucin CVac(TM) CAN-003 Trial Selected for Oral Presentation at the European Cancer Congress Prima BioMed Ltd today announced that the abstract titled "Clinical study of autologous dendritic cell therapy targeting mucin 1 for treatment of ovarian cancer patients in first remission" has ... June 19, 2013 - Marketwired via Yahoo! Finance